Lim H S, Chong A Y, Freestone B, Blann A D, Lip G Y H
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
Diabet Med. 2005 Mar;22(3):249-55. doi: 10.1111/j.1464-5491.2004.01388.x.
Endothelial abnormalities and a hypercoagulable state may contribute to increased cardiovascular risk in diabetes mellitus, particularly in patients with overt cardiovascular disease (CVD). We sought to determine the effect of intensified multi-factorial cardiovascular risk intervention on indices of endothelial abnormality and hypercoagulability in diabetes, and if patients with overt CVD would derive similar benefit as those without.
We measured plasma von Willebrand factor (vWf, an index of endothelial damage/dysfunction), soluble E-selectin (sE-sel, marking endothelial activation) and tissue factor (TF, an initiator of coagulation) by ELISA in 94 patients with diabetes mellitus (38 with CVD and 56 without overt CVD) and 34 comparable controls. Thirty-three patients with CVD and 31 without overt CVD then participated in multi-factorial cardiovascular risk intervention over 1 year.
Plasma levels of vWf (P = 0.009), sE-sel (P < 0.001) and TF (P < 0.001) were significantly higher in diabetic patients compared with controls, with TF highest in patients with overt CVD. Intensive multi-factorial intervention resulted in reductions in glycated haemoglobin (HbA(1c)), total and LDL-cholesterol (all P < 0.05), but no significant weight change. This was associated with reductions in vWf in patients with (by 26%P = 0.003), and without (by 47%, P < 0.001), overt CVD. TF was reduced only in patients without overt CVD (by 45%, P < 0.001). There were no significant changes in sE-sel levels in either group.
Endothelial abnormalities in diabetes are only partially influenced by contemporary intensified multi-factorial cardiovascular risk intervention. These data suggest the need for earlier and more aggressive risk factor intervention.
内皮功能异常和高凝状态可能会增加糖尿病患者的心血管疾病风险,尤其是那些患有明显心血管疾病(CVD)的患者。我们试图确定强化多因素心血管风险干预对糖尿病患者内皮功能异常和高凝状态指标的影响,以及患有明显CVD的患者是否能与未患明显CVD的患者获得相似的益处。
我们通过酶联免疫吸附测定法(ELISA)测量了94例糖尿病患者(38例患有CVD,56例未患明显CVD)和34例对照者的血浆血管性血友病因子(vWf,内皮损伤/功能障碍指标)、可溶性E-选择素(sE-sel,标记内皮激活)和组织因子(TF,凝血启动因子)。然后,33例患有CVD的患者和31例未患明显CVD的患者参加了为期1年的多因素心血管风险干预。
与对照组相比,糖尿病患者的血浆vWf水平(P = 0.009)、sE-sel水平(P < 0.001)和TF水平(P < 0.001)显著更高,其中TF在患有明显CVD的患者中最高。强化多因素干预导致糖化血红蛋白(HbA1c)、总胆固醇和低密度脂蛋白胆固醇降低(均P < 0.05),但体重无显著变化。这与患有明显CVD的患者(降低26%,P = 0.003)和未患明显CVD的患者(降低47%,P < 0.001)的vWf降低有关。TF仅在未患明显CVD的患者中降低(降低45%,P < 0.001)。两组的sE-sel水平均无显著变化。
糖尿病患者的内皮功能异常仅部分受当代强化多因素心血管风险干预的影响。这些数据表明需要更早、更积极地干预危险因素。